These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12880984)

  • 1. Vaccination with minigenes encoding for novel 'self' antigens are effective in DNA-vaccination against neuroblastoma.
    Huebener N; Lange B; Lemmel C; Rammensee HG; Strandsby A; Wenkel J; Jikai J; Zeng Y; Gaedicke G; Lode HN
    Cancer Lett; 2003 Jul; 197(1-2):211-7. PubMed ID: 12880984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA minigene vaccination for adjuvant neuroblastoma therapy.
    Lode HN; Huebener N; Zeng Y; Fest S; Weixler S; Gaedicke G
    Ann N Y Acad Sci; 2004 Dec; 1028():113-21. PubMed ID: 15650237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine hydroxylase-based DNA-vaccination is effective against murine neuroblastoma.
    Lode HN; Pertl U; Xiang R; Gaedicke G; Reisfeld RA
    Med Pediatr Oncol; 2000 Dec; 35(6):641-6. PubMed ID: 11107137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity.
    Huebener N; Fest S; Strandsby A; Michalsky E; Preissner R; Zeng Y; Gaedicke G; Lode HN
    Mol Cancer Ther; 2008 Jul; 7(7):2241-51. PubMed ID: 18645033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivin minigene DNA vaccination is effective against neuroblastoma.
    Fest S; Huebener N; Bleeke M; Durmus T; Stermann A; Woehler A; Baykan B; Zenclussen AC; Michalsky E; Jaeger IS; Preissner R; Hohn O; Weixler S; Gaedicke G; Lode HN
    Int J Cancer; 2009 Jul; 125(1):104-14. PubMed ID: 19291796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.
    Stermann A; Huebener N; Seidel D; Fest S; Eschenburg G; Stauder M; Schramm A; Eggert A; Lode HN
    Cancer Immunol Immunother; 2015 Oct; 64(10):1215-27. PubMed ID: 26076666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A minigene DNA vaccine encoding peptide epitopes derived from Galectin-1 has protective antitumoral effects in a model of neuroblastoma.
    Liebscher L; Weißenborn C; Langwisch S; Gohlke BO; Preissner R; Rabinovich GA; Christiansen N; Christiansen H; Zenclussen AC; Fest S
    Cancer Lett; 2021 Jul; 509():105-114. PubMed ID: 33848518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy.
    Pertl U; Luster AD; Varki NM; Homann D; Gaedicke G; Reisfeld RA; Lode HN
    J Immunol; 2001 Jun; 166(11):6944-51. PubMed ID: 11359856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma.
    Lode HN; Dreier T; Xiang R; Varki NM; Kang AS; Reisfeld RA
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2475-80. PubMed ID: 9482910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of GD2 peptide mimotope DNA vaccines effective against spontaneous neuroblastoma metastases.
    Fest S; Huebener N; Weixler S; Bleeke M; Zeng Y; Strandsby A; Volkmer-Engert R; Landgraf C; Gaedicke G; Riemer AB; Michalsky E; Jaeger IS; Preissner R; Förster-Wald E; Jensen-Jarolim E; Lode HN
    Cancer Res; 2006 Nov; 66(21):10567-75. PubMed ID: 17079481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
    Nagarajan AG; Balasundaram SV; Janice J; Karnam G; Eswarappa SM; Chakravortty D
    Vaccine; 2009 May; 27(21):2804-11. PubMed ID: 19428891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice.
    Marx M; Zumpe M; Troschke-Meurer S; Shah D; Lode HN; Siebert N
    PLoS One; 2018; 13(11):e0207320. PubMed ID: 30452438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma.
    Niethammer AG; Xiang R; Ruehlmann JM; Lode HN; Dolman CS; Gillies SD; Reisfeld RA
    Cancer Res; 2001 Aug; 61(16):6178-84. PubMed ID: 11507070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein.
    Chou CK; Hung JY; Liu JC; Chen CT; Hung MC
    Cancer Gene Ther; 2006 Aug; 13(8):746-52. PubMed ID: 16410824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
    Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
    Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
    Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N
    Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrovirus-mediated gene transfer of B7-1 and MHC class II converts a poorly immunogenic neuroblastoma into a highly immunogenic one.
    Heuer JG; Tucker-McClung C; Gonin R; Hock RA
    Hum Gene Ther; 1996 Nov; 7(17):2059-68. PubMed ID: 8934220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens.
    Schirmbeck R; Reimann J; Kochanek S; Kreppel F
    Mol Ther; 2008 Sep; 16(9):1609-16. PubMed ID: 18612271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model.
    Schreurs MW; Eggert AA; de Boer AJ; Vissers JL; van Hall T; Offringa R; Figdor CG; Adema GJ
    Cancer Res; 2000 Dec; 60(24):6995-7001. PubMed ID: 11156402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous immunisation with a Wilms' tumour 1 epitope and its ubiquitin fusions results in enhanced cell mediated immunity and tumour rejection in C57BL/6 mice.
    Eslami NS; Shokrgozar MA; Mousavi A; Azadmanesh K; Nomani A; Apostolopoulos V; Day S; Amanzadeh A; Alimohammadian MH
    Mol Immunol; 2012 Jul; 51(3-4):325-31. PubMed ID: 22525006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.